Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.05 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

admedus ltd (AMEUF) Snapshot

Open
$0.05
Previous Close
$0.05
Day High
$0.05
Day Low
$0.05
52 Week High
09/4/14 - $0.16
52 Week Low
06/9/15 - $0.05
Market Cap
92.4M
Average Volume 10 Days
3.8K
EPS TTM
--
Shares Outstanding
1.8B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ADMEDUS LTD (AMEUF)

Related News

No related news articles were found.

admedus ltd (AMEUF) Related Businessweek News

No Related Businessweek News Found

admedus ltd (AMEUF) Details

Admedus Limited, a diversified healthcare company, focuses on developing and commercializing next generation technologies. The company is involved in the process of commercializing its tissue engineering technology for regenerative medicine. It provides CardioCel, a cardiovascular scaffold for the repair of congenital heart deformities and heart defects, as well as for the repair and reconstruction of heart valves and vessels. The company is also developing a suite of vaccines that treat and prevent infectious diseases and cancers caused by Herpes Simplex Virus and Human Papillomavirus (HPV). In addition, it manufactures, sells, and distributes bio implants, as well as distributes disposable medical products and medical devices. The company was formerly known as Allied Healthcare Group Limited and changed its name to Admedus Limited in November 2013. Admedus Limited is based in Malaga, Australia.

admedus ltd (AMEUF) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$500.2K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$205.4K
Chief Operating Officer
Total Annual Compensation: A$322.5K
Executive Director
Total Annual Compensation: --
Executive
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

admedus ltd (AMEUF) Key Developments

Admedus Limited Announces Change of Registered Office Address

Admedus Limited announced that, as of June 8, 2015, its registered office and principal place of business has changed. The company’s new registered Office & Principle of Business is: 26 Harris Road, Malaga, WA 6090; Postal Address: PO Box 6879, East Perth, WA 6892.

Admedus Limited Presents at Asia Biotech Invest 2015, May-20-2015 10:00 AM

Admedus Limited Presents at Asia Biotech Invest 2015, May-20-2015 10:00 AM. Venue: Sheraton Hotel & Towers, Hong Kong. Speakers: Julian J. Chick, Chief Operating Officer.

Admedus Limited Expands its Market to Hong Kong

Admedus Limited announced CardioCel had entered the market in Hong Kong. The company has already received initial orders for CardioCel, a bio-scaffold used to repair congenital heart deformities and complex heart defects including repairing heart valves. Entry into Hong Kong continues the expansion of CardioCel into Asian markets, as part of Admedus's global product launch strategy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMEUF:US $0.05 USD 0.00

AMEUF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMEUF.
View Industry Companies
 

Industry Analysis

AMEUF

Industry Average

Valuation AMEUF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.8x
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADMEDUS LTD, please visit www.admedus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.